Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

AstraZeneca stock dives 9% after heart drug trial misses target

  • Posted on July 9, 2026
  • By CNBC
  • 0 Views
  • 1 min read
AstraZeneca stock dives 9% after heart drug trial misses target
AstraZeneca stock dives 9% after heart drug trial misses target

AstraZeneca stock dives 9% after heart drug trial misses target continue reading...

Author
CNBC

You May Also Like